EP 4055176 A1 20220914 - ANTI-GUCY2C VACCINES AND VACCINATION
Title (en)
ANTI-GUCY2C VACCINES AND VACCINATION
Title (de)
ANTI-GUCY2C-IMPFSTOFFE UND IMPFUNG
Title (fr)
VACCINS ANTI-GUCY2C ET VACCINATION
Publication
Application
Priority
- US 202062932499 P 20201107
- US 202062933361 P 20201108
- US 2020059752 W 20201109
Abstract (en)
[origin: WO2022098372A1] Compositions comprising a modified adenovirus AD5.F35 which includes coding sequence of soluble GUCY2C extracellular domain sequences are disclosed. Compositions comprising a Listeria monocytogenes vector which includes coding sequence of soluble GUCY2C extracellular domain sequences are disclosed. Methods of treating individuals diagnosed with cancer/tumors expressing GUCY2C methods of preventing micro-metastasis are disclosed.
IPC 8 full level
C12N 15/861 (2006.01); A61K 35/76 (2015.01); A61K 48/00 (2006.01); C12N 5/10 (2006.01); C12N 7/00 (2006.01); C12N 15/09 (2006.01); C12N 15/86 (2006.01)
CPC (source: EP)
A61K 39/001154 (2018.08); C12N 9/88 (2013.01); C12N 15/86 (2013.01); C12Y 406/01002 (2013.01); A61K 2039/522 (2013.01); A61K 2039/525 (2013.01); A61K 2039/545 (2013.01); A61K 2039/572 (2013.01); C12N 2710/10343 (2013.01); C12N 2800/22 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2022098372 A1 20220512; AU 2020475819 A1 20220623; EP 4055176 A1 20220914; EP 4055176 A4 20240417
DOCDB simple family (application)
US 2020059752 W 20201109; AU 2020475819 A 20201109; EP 20960974 A 20201109